XTX Topco’s Achieve Life Sciences ACHV Stock Holding History

XTX Topco’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$53.6K	Sell	18,218 -874	-5%	-$3.88K	﹤0.01%	3297
2025 Q4	$94.9K	Sell	19,092 -66,763	-78%	-$291K	﹤0.01%	2648
2025 Q3	$270K	Buy	+85,855	New	+$236K	0.01%	1588
2025 Q2	–	Sell	-37,021	Closed	-$98.8K	–	2282
2025 Q1	$98.8K	Buy	+37,021	New	+$115K	0.01%	1872
2023 Q3	–	Sell	-14,841	Closed	-$77K	–	1512
2023 Q2	$77K	Buy	+14,841	New	+$104K	0.01%	1193

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco's ACHV Position: Q1 2026 in Review

XTX Topco reduced its Achieve Life Sciences (ACHV) stake by 4.6% in Q1 2026, selling an estimated $3.88K and leaving 18,218 shares worth $53.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3297.

XTX Topco first reported a position in ACHV in Q2 2023 and has held it in 5 quarters since. The position peaked at $270K in Q3 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

XTX Topco held 18,218 shares of Achieve Life Sciences worth $53.6K as of Q1 2026.
XTX Topco sold 874 Achieve Life Sciences shares in Q1 2026, an estimated $3.88K.
Achieve Life Sciences made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3297 holding.
XTX Topco first reported a position in Achieve Life Sciences in Q2 2023 and has held it in 5 quarters since.
XTX Topco's Achieve Life Sciences position peaked at $270K in Q3 2025.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.